Copertina

Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Ferraz-Amaro, Ivan
Natura:	Recurso digital
Pubblicazione:	Zenodo 2026
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Organ Damage and Associated Factors in Chinese Patients With Systemic Lupus Erythematosus
di: Jiaying Zhang, et al.
Pubblicazione: (2025)

Serum Endocan in Systemic Lupus Erythematosus: Implication for Endothelial Dysfunction and Cardiovascular Risk
di: Aya A. El Shintenawy, et al.
Pubblicazione: (2026)

Statistical analysis plan for Thoracic Ultrasound and Pulmonary Diseases in Systemic Lupus Erythematosus
di: Langkilde, Henrik Zachar
Pubblicazione: (2025)

A Novel Preclinical Murine Model of Systemic Lupus Erythematosus–Like Cardiovascular Disease
di: Marice K. McCrorey, et al.
Pubblicazione: (2024)

Clinical Characteristics and Risk Factors for Lupus Nephritis in Tunisian Patients With Systemic Lupus Erythematosus
di: Mourad Elghali, et al.
Pubblicazione: (2025)

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia
di: Kelly Corbitt, et al.
Pubblicazione: (2024)

Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis
di: Yurilu A. Gonzalez Moret, et al.
Pubblicazione: (2024)

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia‐Pacific Lupus Collaboration Longitudinal Cohort Study
di: Amanda M. Saracino, et al.
Pubblicazione: (2026)

Changes of Peripheral T Cells in Systemic Lupus Erythematosus Patients
di: Juanfeng Lao, et al.
Pubblicazione: (2025)

Concordance between Carotid and Femoral Ultrasound for the Diagnosis of Subclinical Atherosclerosis in Patients with Low or Intermediate Cardiovascular Risk
di: AUGUSTO J. LÉPORI
Pubblicazione: (2016)

Weighing Dose‐Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
di: Brian Meng‐Hsun Li, et al.
Pubblicazione: (2026)

The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis
di: Hermine I. Brunner, et al.
Pubblicazione: (2026)

Evaluating Neuropsychiatric Disease in Mouse Models of Systemic Lupus Erythematosus
di: Baruh Polis, et al.
Pubblicazione: (2025)

B‐ and T‐Lymphocyte Attenuator in Systemic Lupus Erythematosus Disease Pathogenesis
di: Andrew C. Vendel, et al.
Pubblicazione: (2024)

60 | Treatment With Anifrolumab Prevents Long‐Term Cardiovascular Damage Accrual Compared With Real‐World Standard of Care in Patients With Systemic Lupus Erythematosus: Findings From the LASER Study
Pubblicazione: (2026)

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications
di: Tomás Cerdó, et al.
Pubblicazione: (2026)

Evaluation of the Impact of Anti‐C1q Autoantibodies on Cardiovascular Outcomes in Systemic Lupus Erythematosus
di: Jessica S. Kleer, et al.
Pubblicazione: (2025)

Investigation of the Effect of Hormonal Therapy on Lupus Pathology and Reproductive System Damages in a Pristane‐Induced Mouse Model of Systemic Lupus Erythematosus
di: Gabriela Boneva, et al.
Pubblicazione: (2025)

Measuring Frailty in Systemic Lupus Erythematosus
di: Patricia Katz, et al.
Pubblicazione: (2025)

Cytokine and IRF5 Gene Polymorphisms Associated With Susceptibility and Organ Damage in Systemic Lupus Erythematosus
di: Ines Allam, et al.
Pubblicazione: (2025)

Prevalence and Risk Factors of Systemic Lupus Erythematosus in Patients With Chronic Cutaneous Lupus: A Bicentric Study Employing Three Classification Criteria
di: Noureddine Litaiem, et al.
Pubblicazione: (2026)

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus
di: Alexa G. Ries, et al.
Pubblicazione: (2026)

Biopsychosocial Predictors of Self‐Care Adherence in Patients With Systemic Lupus Erythematosus
di: Icaro Moreira Costa, et al.
Pubblicazione: (2026)

Identification of Lupus Erythematosus Cells and Ragocytes in Peripheral Blood from a Dog with Systemic Lupus Erythematosus
di: Samantha L. Braman, et al.
Pubblicazione: (2026)

Social Connections in Older Adults With Systemic Lupus Erythematosus: Patient Perspectives
di: Sarah B. Lieber, et al.
Pubblicazione: (2025)

Effect of Shared Decision‐Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study
di: Ryusuke Yoshimi, et al.
Pubblicazione: (2024)

Deep Learning for Cardiovascular Risk Assessment: Proxy Features from Carotid Sonography as Predictors of Arterial Damage
di: Balada, Christoph, et al.
Pubblicazione: (2025)

Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus
di: Diana Schellin, et al.
Pubblicazione: (2026)

Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission
di: Nikolaos Papazoglou, et al.
Pubblicazione: (2025)

Uncovering Genetic Variation in Systemic Lupus Erythematosus Risk Variants in Indigenous Peruvians
di: Cristina M. Lanata, et al.
Pubblicazione: (2025)

Predicting the Risk of Fundus Lesions in Systemic Lupus Erythematosus: A Nomogram Model
di: Huan Xie, et al.
Pubblicazione: (2024)

Genetics of Childhood‐Onset Systemic Lupus Erythematosus
di: Raffaella Carlomagno, et al.
Pubblicazione: (2025)

Remodeling the Inflammatory Microenvironment: Nanomaterial‐Based Targeted Strategies for Systemic Lupus Erythematosus and Lupus Nephritis
di: Cheng Zhou, et al.
Pubblicazione: (2026)

146 | Untargeted Quantitative Serum Proteomics in Patients With Systemic Lupus Erythematosus Demonstrates Associations With Ethnicity and Disease Phenotypes
Pubblicazione: (2026)

CD39 Expression in Peripheral CD4+ T Lymphocytes Is Associated With Disease Activity in Patients With Systemic Lupus Erythematosus
di: Hao Jin, et al.
Pubblicazione: (2026)

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active
di: Yanjie Hao, et al.
Pubblicazione: (2025)

Severe Hypocalcemia as an Atypical Manifestation of Seronegative Celiac Disease in a Patient with Systemic Lupus Erythematosus: Case Report
di: Andrés Felipe Mejía-Cardona
Pubblicazione: (2023)

Choosing to End African American Health Disparities in Patients With Systemic Lupus Erythematosus
di: Matthew H. Liang, et al.
Pubblicazione: (2024)

Association Between Frailty Status and Readmissions in Hospitalized Patients With Systemic Lupus Erythematosus
di: Christopher Leung, et al.
Pubblicazione: (2024)

Energy‐Based Devices for the Treatment of Cutaneous Lesions in Patients With Lupus Erythematosus and Dermatomyositis
di: Hae Chang Joh, et al.
Pubblicazione: (2026)